CClinicalTrials.gg
Sign In
Status unknownNCT05145790MOODUpdated Dec 15, 2021

The Place of Consultations Specializing in the Diagnosis of Mood Disorders in Strasbourg University Hospital

An observational study in Mood Disorders, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-15.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Nov 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
197
Ages
18 Years and older
Sex
All
01

Study summary

Mood disorders (depressive disorders and bipolar disorders) are among the ten most worrying diseases of the 21st century according to the WHO.

In order to support psychiatrists in their diagnostic reflection, structures have been created. Since 2009, the Psychiatry Service 2 within the Psychiatry, Mental Health and Addictology Pole of the University Hospitals of Strasbourg has offered specialized consultations in mood disorders.

More than 10 years after the creation of these consultations, it seems interesting to study the profile of the users and to describe the nature of the reports of these in-depth evaluation consultations (diagnosis, therapeutic advice)

02

Conditions studied

  • Mood Disorders

Browse trials for

Keywords

  • Mood Disorders
03

In context

Mood Disorders

584 studies on the registry are indexed under Mood Disorders; 117 are open to participants now.

This study's planned enrollment of 197 is close to the median of 180 across 145 observational studies indexed under Mood Disorders.

Browse Mood Disorders studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Major subject with pecialized primary consultation highlighting symptoms of mood disorders

Inclusion criteria

  • Major subject
  • Specialized primary consultation highlighting symptoms of mood disorders with Prof. Berstchy in the psychiatry department 2 in the University Hospital of Strasbourg (patients whose consultation request was linked to symptoms or a diagnosis of ADHD will not be included in the study population).
  • Consultation that took place in 2018 and 2019.
  • Patient who did not express his opposition to the reuse of his data for scientific research purposes.

Exclusion criteria

Exclusion criteria:

  • Patient opposition to the use of their personal data for scientific research purposes.
  • Prior existence of a previous specialist consultation in mood disorders with Prof. Berstchy (the information collected during the first consultation is not accessible)
  • Patient under curatorship, guardianship or legal protection
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
197 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Descriptive study of the clinical characteristics of patients coming to consultations specializing in mood disorders in Strasbourg University Hospitals

    Time frame: Files analysed retrospectively from January 01, 2018 to December 31, 2019 will be examined]

07

Study locations

1 of 1 sites recruiting
  • Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg
    Strasbourg, 67091, France
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 15, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05145790
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Dec 6, 2021
Start date
Aug 15, 2021
Primary completion
Mar 2022 (estimated)
Completion
Mar 15, 2022 (estimated)
Last update
Dec 15, 2021

Study contacts

Gilles BERTSCHY, MD, PhD
Contact
gilles.bertschy@chru-strasbourg.fr
33 3 88 11 65 48
Saïd CHAYER, PhD, HDR
Contact
said.chayer@chru-strasbourg.fr
Gilles BERTSCHY, MD, PhD
principal investigator · Service de psychiatrie 2 - Hôpitaux Universitaires de Strasbourg

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Mood Disorders→

Other studies from this sponsor

University Hospital, Strasbourg, France

Start the discussion